Atrial Fibrillation (cont.)
Daniel Lee Kulick, MD, FACC, FSCAI
Dr. Kulick received his undergraduate and medical degrees from the University of Southern California, School of Medicine. He performed his residency in internal medicine at the Harbor-University of California Los Angeles Medical Center and a fellowship in the section of cardiology at the Los Angeles County-University of Southern California Medical Center. He is board certified in Internal Medicine and Cardiology.
Charles Patrick Davis, MD, PhD
Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.
In this Article
- Atrial fibrillation facts
- What is atrial fibrillation?
- What causes atrial fibrillation?
- What are the symptoms of atrial fibrillation?
- What are the complications of atrial fibrillation?
- What are the risk factors for developing atrial fibrillation?
- How is atrial fibrillation diagnosed?
- What is the treatment for atrial fibrillation?
- Reversing the risk factors that cause atrial fibrillation
- Slowing the heart rate with medications
- Anticoagulation to prevent blood clots and strokes
- Converting atrial fibrillation to a normal rhythm
- Procedures for treating and preventing atrial fibrillation
- What is new in atrial fibrillation?
- Atrial Fibrillation - Slideshow
- Take the Atrial Fibrillation Quiz!
- Heart Disease - Slideshow
- Atrial Fibrillation A-Fib FAQs
- Find a local Cardiologist in your town
Procedures for treating and preventing atrial fibrillation
After successful cardioversion many patients (up to 75%) may experience recurrence of atrial fibrillation within 12 months. Therefore, many patients will need long-term treatment with medications to prevent a recurrence of atrial fibrillation; however, medication(s) are effective only 50% to 75% of the time in preventing recurrence. Moreover, many patients cannot tolerate the side effects of long-term medication. For these reasons, several procedures have been developed to treat and prevent recurrence of atrial fibrillation; they include:
- Ablation of the AV node with implantation of a pacemaker
- Implantation of a pacemaker
- Implantation of an atrial defibrillator
- Maze procedure
- Isolation of the pulmonary vein
Ablation of the AV node with implantation of a pacemaker. Ablation of the AV node is a procedure that destroys the AV node so that the atrial electrical discharges cannot pass through the AV node to activate the ventricles. The procedure usually is performed in a cardiac catheterization unit or an electrophysiology unit of a hospital.
- Procedure. For ablation of the AV node, patients are given a local anesthetic to minimize pain and are mildly sedated with intravenous medications. Using X-ray guidance, a wire (catheter) is inserted through a vein in the groin to reach the heart. Electrical recordings from inside the heart help to locate the AV node. The AV node is destroyed (ablated) using heat delivered by the catheter. After successful ablation of the AV node, electrical discharges from the atria can no longer reach the ventricles. Destruction of the AV node (whether by catheter ablation or by disease that occurs with age) can lead to an excessively slow rate of ventricular contractions (slow heart rate). Therefore, a pacemaker is implanted in order to provide the heart with a minimum safe heart rate.
- Benefits of ablation of the AV node. The benefits of ablation of the AV node and implantation of a pacemaker include:
- resumption of a regular heart rate (even though a pacemaker may be determining the heart rate);
- relief from palpitations, fainting, dizziness, and shortness of breath; and
- ability to stop medications and avoid their potentially serious side effects.
Pacemakers. Permanent pacemakers are battery-operated devices that generate electrical discharges that cause the heart to beat more rapidly when the heart is beating too slowly. Recent studies suggest that some patients with recurrent paroxysmal atrial fibrillation can benefit from the implantation of a permanent pacemaker. Although the reasons for this benefit are unknown, regular electrical pulses from the pacemakers may prevent the recurrence of atrial fibrillation. Furthermore, newer pacemakers that can stimulate two different sites within the atria (dual site atrial pacing) may be even more effective than standard pacemakers in preventing atrial fibrillation. Nevertheless, permanent pacemaker implantation cannot be considered as standard non-medication treatment for atrial fibrillation.
Implantable atrial defibrillators. Implantable atrial defibrillators can detect and convert atrial fibrillation back to a normal rhythm by using high-energy shocks. By detecting atrial fibrillation and terminating it quickly, doctors hope that these devices will prevent recurrences of atrial fibrillation over the long term.
Atrial defibrillators are surgically implanted within the chest under local anesthesia. These devices deliver high-energy shocks to the heart that are somewhat painful. Atrial defibrillators are not useful in patients with chronic sustained atrial fibrillation and are suitable only for patients with infrequent episodic attacks of atrial fibrillation.
Maze procedure. Many doctors believe that the atria cannot fibrillate if they are sectioned into small pieces so that the conduction of the electrical current through the atria is interrupted. During the Maze procedure, numerous incisions are made in the atria to control the irregular heartbeat and restore a regular rhythm to the heart.
- Procedure. The Maze procedure is most commonly performed via open heart surgery. Some electrophysiologists (doctors specially trained to treat abnormalities of rhythm) are now attempting to perform the Maze procedure using catheters inside the heart that are passed through a vein in the groin without open heart surgery. Unfortunately, the success rate using the catheter is below 50% and complications (such as strokes) may occur.
- Effectiveness of the Maze procedure. The Maze procedure done surgically (using open heart surgery) has been reported to correct atrial fibrillation in 90% to 99% of patients. Only 15% to 20% of the patients need a pacemaker after surgery, and there is only a 30% chance of requiring long-term medications to maintain a normal rhythm.
- Risks of the Maze procedure. The surgical Maze procedure involves open heart surgery and the pumping of blood by an external bypass pump while the surgery is performed, much like patients undergoing cardiac bypass surgery. The complications are not insignificant and include stroke, bleeding, infection, and death. Therefore, doctors usually do not recommend a surgical Maze procedure for the treatment of atrial fibrillation unless the patient is undergoing open heart surgery for another condition (such as for coronary artery bypass or replacement or repair of a diseased heart valve).
Viewers share their comments
Find out what women really need.